paclitaxel has been researched along with Oligohydramnios in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, RS; Shieh, MP | 1 |
| Bader, AA; Petru, E; Pristauz, G; Schlembach, D; Tamussino, KF | 1 |
| Berveiller, P; Goffinet, F; Goldwasser, F; Mir, O; Pons, G; Ropert, S; Treluyer, JM | 1 |
1 review(s) available for paclitaxel and Oligohydramnios
| Article | Year |
|---|---|
Emerging therapeutic options for breast cancer chemotherapy during pregnancy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Lapatinib; Oligohydramnios; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Quinazolines; Receptor, ErbB-2; Taxoids; Trastuzumab; Vinblastine; Vinorelbine | 2008 |
2 other study(ies) available for paclitaxel and Oligohydramnios
| Article | Year |
|---|---|
Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Oligohydramnios; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome | 2011 |
Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Infant, Newborn; Male; Oligohydramnios; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Trastuzumab | 2007 |